These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11686534)

  • 41. Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from Burr parsley (Caucalis platycarpos L.).
    Orsolić N; Bevanda M; Kujundzić N; Plazonic A; Stajcar D; Kujundzić M
    Planta Med; 2010 May; 76(8):773-9. PubMed ID: 20033866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
    Favoulet P; Magnin G; Guilland JC; Beltramo JL; Osmak L; Benoit L; Rat P; Douvier S; Duvillard C; Chauffert B
    Eur J Surg Oncol; 2001 Feb; 27(1):59-64. PubMed ID: 11237494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
    Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat.
    Prat F; Chapelon JY; el Fadil FA; Theillère Y; Ponchon T; Cathignol D
    Br J Cancer; 1993 Jul; 68(1):13-7. PubMed ID: 8318402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.
    Elias D; Blot F; El Otmany A; Antoun S; Lasser P; Boige V; Rougier P; Ducreux M
    Cancer; 2001 Jul; 92(1):71-6. PubMed ID: 11443611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.
    Gómez Portilla A; Cendoya I; Olabarría I; Martínez de Lecea C; Gómez Martínez de Lecea C; Gil A; Martín E; Muriel J; Magrach L; Romero E; Lirola A; Guede N; Moraza N; Fernández E; Kvadatze M; Valdovinos M; Larrabide I; Ruiz de Alegría N; Fernández JL; Castillo C; Rua O; Ulibarrena MA
    Rev Esp Enferm Dig; 2009 Feb; 101(2):97-102, 103-6. PubMed ID: 19335045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Short-term intraperitoneal infusion of cisplatin and OK-432 for a case of malignant mesothelioma of the peritoneum].
    Kuwabara K; Ishida H; Ohsawa T; Nakata H; Murata N; Hashimoto D; Adachi A; Itoyama S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2333-5. PubMed ID: 12484067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data].
    Salle B; Gilly FN; Carry PY; Sayag A; Brachet A; Braillon G
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):369-71. PubMed ID: 8360435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
    Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
    Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
    de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Jablonski KA
    Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peritoneal mesothelioma in a case of inguinal hernia. A review of the literature.
    Torretta A; La Torre V; Sorcini A; Panarese A; Tonini E; Zeri KP; Mascagni D; Arcieri S; Giacomelli L; Filippini A
    Ann Ital Chir; 2003; 74(5):583-7. PubMed ID: 15139717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Tanimura H; Tsubota YT
    Hepatogastroenterology; 2004; 51(58):1073-83. PubMed ID: 15239250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
    Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
    Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis.
    Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
    In Vivo; 1987; 1(1):43-6. PubMed ID: 2979763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
    Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.